Politician trade (House)

HealthEquity (HQY): Rep. Blake D. Moore (UT01) disclosed a purchase $1K–$15K

Rep. Blake D. Moore (UT01) disclosed a purchase of HealthEquity in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
78 days
Disclosure lag
Traded
Apr 30, 2021
Disclosed
Jul 17, 2021

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 26, 2021CongressDisclosed purchase of HQY — reported range $1,001 - $15,000
  2. Apr 30, 2021 · this disclosureCongressDisclosed purchase of HQY — reported range $1,001 - $15,000

What came next

  1. May 11, 2021CongressDisclosed purchase of HQY — reported range $1,001 - $15,000
  2. May 12, 2021CongressDisclosed purchase of HQY — reported range $1,001 - $15,000
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for HealthEquity

For HealthEquity, OQRO holds 12 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HQY page.

Other recent filings by Rep. Blake D. Moore (UT01)

The full history of Rep. Blake D. Moore (UT01) is on the profile page.

How this filing works

Explore the data

Other disclosures at HealthEquity

Everything OQRO holds on this company is on its HQY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data